HRTS Among Its Peers
End-of-day Nov 13, 2026 · 1 ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.6% | +1.8% | +5.4% | +5.3% | +11.2% | +15.9% | — | — | +51.6% |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$126 of every $1,000 in HRTS is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 12.62% | $1,261.51 | 5,107 | $7.3M |
| 2 | TMOThermo Fisher Scientific | Healthcare | 5.31% | $530.96 | 4,381 | $3.1M |
| 3 | RHHBYRoche AG | Healthcare | 4.32% | $432.16 | 41K | $2.5M |
| 4 | MRKMerck | Healthcare | 4.19% | $419.12 | 16K | $2.4M |
| 5 | KODKodiak Sciences | Healthcare | 4.05% | $405.38 | 22K | $2.3M |
| 6 | BBIOBridgebio Pharma | Healthcare | 3.69% | $369.06 | 27K | $2.1M |
| 7 | GILDGilead Sciences | Healthcare | 3.39% | $338.86 | 12K | $2.0M |
| 8 | RVMDRevolution Medicines | Healthcare | 3.26% | $325.86 | 11K | $1.9M |
| 9 | DHRDanaher | Healthcare | 3.10% | $309.92 | 7,704 | $1.8M |
| 10 | UNHUnitedhealth Group | Healthcare | 3.07% | $306.91 | 4,372 | $1.8M |
| 11 | NOVO-B.CONovo Nordisk A/S | Healthcare | 2.96% | $296.37 | 42K | $1.7M |
| 12 | AZN.LAstrazeneca | Healthcare | 2.93% | $292.61 | 9,157 | $1.7M |
| 13 | ABTAbbott Laboratories | Healthcare | 2.88% | $288.00 | 15K | $1.7M |
| 14 | JNJJohnson & Johnson | Healthcare | 2.87% | $287.44 | 5,851 | $1.7M |
| 15 | NOVN.SWNovartis AG | Healthcare | 2.83% | $283.33 | 10K | $1.6M |
HRTS has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 12.62% |
| 2 | TMO | Thermo Fisher Scientific | 5.31% |
| 3 | RHHBY | Roche AG | 4.32% |
| 4 | MRK | Merck & | 4.19% |
| 5 | KOD | Kodiak Sciences | 4.05% |
| 6 | BBIO | Bridgebio Pharma | 3.69% |
| 7 | GILD | Gilead Sciences | 3.39% |
| 8 | RVMD | Revolution Medicines | 3.26% |
| 9 | DHR | Danaher | 3.10% |
| 10 | UNH | Unitedhealth Group | 3.07% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| HRTS | 0.95 | 1.52 | 17.4% | −11.0% | 0.48 | $99 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.47 |
| Dec 11, 2024 | Dec 12, 2024 | $0.47 |